Adherium Ltd - Asset Resilience Ratio

Latest as of June 2025: 1.23%

Adherium Ltd (ADR) has an Asset Resilience Ratio of 1.23% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Adherium Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

AU$43.26K
≈ $30.61K USD Cash + Short-term Investments

Total Assets

AU$3.52 Million
≈ $2.49 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2023)

This chart shows how Adherium Ltd's Asset Resilience Ratio has changed over time. See ADR net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Adherium Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Adherium Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$43.26K 1.23%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$43.26K 1.23%

Asset Resilience Insights

  • Limited Liquidity: Adherium Ltd maintains only 1.23% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Adherium Ltd Industry Peers by Asset Resilience Ratio

Compare Adherium Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Vitrolife AB
ST:VITR
Medical Devices 7.27%
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
Medical Devices 19.31%
Tellgen Corp
SHE:300642
Medical Devices 8.60%
Lumos Diagnostics Holdings Ltd
AU:LDX
Medical Devices 9.40%
T&R Biofab Co. Ltd
KQ:246710
Medical Devices 0.12%
Ok Biotech Co Ltd
TW:4155
Medical Devices 0.32%
Promimic AB
ST:PRO
Medical Devices 8.62%
Memphasys Ltd
AU:MEM
Medical Devices 0.00%

Annual Asset Resilience Ratio for Adherium Ltd (2017–2023)

The table below shows the annual Asset Resilience Ratio data for Adherium Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-06-30 71.58% AU$9.08 Million
≈ $6.42 Million
AU$12.68 Million
≈ $8.97 Million
+9.67pp
2022-06-30 61.91% AU$5.28 Million
≈ $3.74 Million
AU$8.53 Million
≈ $6.04 Million
-26.21pp
2021-06-30 88.13% AU$15.02 Million
≈ $10.62 Million
AU$17.04 Million
≈ $12.06 Million
+19.89pp
2020-06-30 68.23% AU$4.58 Million
≈ $3.24 Million
AU$6.72 Million
≈ $4.75 Million
+34.23pp
2019-06-30 34.00% AU$763.00K
≈ $539.87K
AU$2.24 Million
≈ $1.59 Million
-47.88pp
2018-06-30 81.88% AU$12.54 Million
≈ $8.88 Million
AU$15.32 Million
≈ $10.84 Million
-8.90pp
2017-06-30 90.79% AU$22.78 Million
≈ $16.12 Million
AU$25.09 Million
≈ $17.75 Million
--
pp = percentage points

About Adherium Ltd

AU:ADR Australia Medical Devices
Market Cap
$7.37 Million
AU$10.42 Million AUD
Market Cap Rank
#27548 Global
#1434 in Australia
Share Price
AU$0.00
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.01
All Time High
AU$10.31
About

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides … Read more